Work

Frailty across the course of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

Year: 2024

Type: article

Abstract: Background: Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is a chronic, indolent B cell malignancy that predominantly impacts older adults. CLL/SLL-related symptoms impair the quality of life and physical functioning of patients with CLL/SLL compared to the general population, but the impact of CLL/SLL on a patient’s frailty is unclear. Since 2014, multiple novel therapies (i.e., ibrutinib, acalabrutinib, zanubrutinib, and venetoclax) with improved efficacy and safety were approved to treat CLL/SLL which could substantially benefit older, frailer patients. However, clinical trials frequently exclude older, frailer patients and the uptake of novel therapies in clinical care settings in this patient population is unknown.

Source: Iowa Research Online (The University of Iowa)

DOI: 10.25820/etd.007535

Author: Siebert, Vanessa E.

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6945986290

FWCI:

Cites:

Cited by:

Related to: